Business Daily Media

Business Marketing

.

Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts

  • Written by ACN Newswire - Press Releases

Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts

SINGAPORE, Jun 1, 2020 - (ACN Newswire) - SGX-listed Singapore eDevelopment Limited's (the "Company") (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc. ("Impact Biomedical"), would like to update its stakeholders on its suite of antiviral and medical technologies ("Suite"). This Suite is valued at USD 1.39 Billion (SGD 1.97 Billion)

Read more //?#

Popular

Medius delivers seamless cross-border payments with TransferMate

STOCKHOLM, June 30, 2021 – Medius, a leading provider of spend management solutions, is announcing its partnership with TransferMate, the leader in payments infrastructure as a service, to offer Medius customers an integrate...

Dirty Money: Why Technology Needs to Take the Lead in the Battle with Fraud

For years, organisations and criminals have been involved in a digital arms race. Business processes have increased in sophistication, but so have the fraudulent attacks designed to undermine them. This battle escalated during...

CA ANZ responds to recent release of FASEA reforms

Chartered Accountants Australia and New Zealand (CA ANZ) welcomes the release of the Financial Adviser Standards and Ethics Authority’s (FASEA’s) draft legislation for five out of the seven standards.   With the next round of ...